Heart Failure: Clinical Trials

10 trials for Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 withdrawn. 10 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Withdrawn 10
Phase 22Withdrawn 2

Follow Heart Failure: new trials by email Literature Review of Heart Failure trials Research Report on Heart Failure

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure
Furosemide Pill 150% equivalent iv dose, Furosemide Pill 200% equivalent iv dose, Furosemide Injection - Heart Failure
Phase 2 / Phase 3WithdrawnJan Kochanowski University2022-12-072025-02-20
AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure
Ad5.hAC6, Placebo - Heart Failure
Phase 3WithdrawnRenova Therapeutics2019-06-012019-06-07
CRT Improved Clinical Response UK Trial
Device programming - Cardiac Failure
Phase 3WithdrawnAston University2016-03-012023-08-02
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage
Tadalafil, Placebo - Heart Failure, Pulmonary Hypertension
Phase 3WithdrawnMassachusetts General Hospital2013-10-012017-09-12
Renal Denervation in Patients With Advanced Heart Failure
Standard steerable Marinr RF ablation Catheter (5F or 7F) - Heart Failure
Phase 3WithdrawnBursa Postgraduate Hospital2013-04-012013-07-24
Bumetanide Versus Furosemide in Heart Failure
Furosemide, Bumetanide, furosemide - Heart Failure
Phase 3WithdrawnLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2011-01-012014-03-27
Nebulized Albuterol for Congestive Heart Failure Exacerbation
Albuterol, Normal Saline - Congestive Heart Failure
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2009-04-012013-10-10
Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure
Pantoprazole - Congestive Heart Failure
Phase 3WithdrawnJohann Wolfgang Goethe University Hospital2008-08-012014-02-11
Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure
Hattler Respiratory Assist Catheter - Emphysema, Acute Respiratory Distress Syndrome
Phase 3WithdrawnAlung Technologies2005-11-012015-12-29
An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)
Nesiritide - Coronary Artery Bypass Surgery, Coronary Heart Disease
Phase 3WithdrawnScios, Inc.2016-09-20

Narrower conditions

Asthma (1)  ·  Coronary Disease (1)  ·  Emphysema (1)  ·  Hypertension, Pulmonary (1)  ·  Insulin Resistance (1)  ·  Myocardial Ischemia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Renal Insufficiency (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Insufficiency (1)

Broader conditions

Cardiovascular Diseases (10)  ·  Heart Diseases (10)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Vascular Diseases (2)  ·  Bronchial Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Hypertension (1)

Interventions

Furosemide (2)  ·  Albuterol (1)  ·  Bumetanide (1)  ·  Natriuretic Peptide, Brain (1)  ·  Pantoprazole (1)  ·  Saline Solution (1)  ·  Sucrose (1)  ·  Tadalafil (1)

Sponsors

Alung Technologies (1)  ·  Aston University (1)  ·  Bursa Postgraduate Hospital (1)  ·  Jan Kochanowski University (1)  ·  Johann Wolfgang Goethe University Hospital (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Massachusetts General Hospital (1)  ·  Renova Therapeutics (1)  ·  Scios, Inc. (1)  ·  University of California, San Francisco (1)

Countries

United States (2)  ·  Canada (1)  ·  Germany (1)  ·  Poland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Ishir Bhan, MD, MPH (1)  ·  Janusz Sielski, MD, PhD (1)  ·  John C. Stein, MD. (1)  ·  Neville G Suskin, MBChB, MSc (1)  ·  Nichola Seare, PhD (1)  ·  Ravi I Thadhani, MD, MPH (1)  ·  Steven Tsui, MD (1)

NIH funding

R01HL119155 (1)